NEW YORK (GenomeWeb News) — Emory University has added one of Corning’s label-free screening systems for use in its drug discovery research programs, the company said yesterday.
The university bought the Epic System for use in its Emory Chemical Biology Discovery Center, which is part of the National Institutes of Health-funded Molecular Libraries Screening Centers Network. The MLSCN includes ten screening centers that work to develop new chemical probes for drug research.
The Epic System is able to conduct biochemical and cell-based assays without radioactive or fluorescent dyes that could interfere with chemical reactions, said Corning.
Ron Verkleeren, who is business director for the Epic System, said in a statement that the instrument’s ability to monitor real-time responses of small molecular compounds in living cells will help streamline the university’s search for new drugs.
Financial terms of the agreement were not released.